| Literature DB >> 30050467 |
Andreas Güldner1, Robert Huhle1, Alessandro Beda1,2, Thomas Kiss1, Thomas Bluth1, Ines Rentzsch1,3, Sarah Kerber1, Nadja C Carvalho1,2, Michael Kasper4, Paolo Pelosi5, Marcelo G de Abreu1.
Abstract
In experimental acute respiratory distress syndrome (ARDS), random variation of tidal volumes (VT ) during volume controlled ventilation improves gas exchange and respiratory system mechanics (so-called stochastic resonance hypothesis). It is unknown whether those positive effects may be further enhanced by periodic VT fluctuation at distinct frequencies, also known as deterministic frequency resonance. We hypothesized that the positive effects of variable ventilation on lung function may be further amplified by periodic VT fluctuation at specific frequencies. In anesthetized and mechanically ventilated pigs, severe ARDS was induced by saline lung lavage and injurious VT (double-hit model). Animals were then randomly assigned to 6 h of protective ventilation with one of four VT patterns: (1) random variation of VT (WN); (2) P04, main VT frequency of 0.13 Hz; (3) P10, main VT frequency of 0.05 Hz; (4) VCV, conventional non-variable volume controlled ventilation. In groups with variable VT , the coefficient of variation was identical (30%). We assessed lung mechanics and gas exchange, and determined lung histology and inflammation. Compared to VCV, WN, P04, and P10 resulted in lower respiratory system elastance (63 ± 13 cm H2O/L vs. 50 ± 14 cm H2O/L, 48.4 ± 21 cm H2O/L, and 45.1 ± 5.9 cm H2O/L respectively, P < 0.05 all), but only P10 improved PaO2/FIO2 after 6 h of ventilation (318 ± 96 vs. 445 ± 110 mm Hg, P < 0.05). Cycle-by-cycle analysis of lung mechanics suggested intertidal recruitment/de-recruitment in P10. Lung histologic damage and inflammation did not differ among groups. In this experimental model of severe ARDS, periodic VT fluctuation at a frequency of 0.05 Hz improved oxygenation during variable ventilation, suggesting that deterministic resonance adds further benefit to variable ventilation.Entities:
Keywords: acute respiratory distress syndrome; experimental model; gas exchange; lung damage; lung inflammation; mechanical ventilation; respiratory mechanics; variable ventilation
Year: 2018 PMID: 30050467 PMCID: PMC6052143 DOI: 10.3389/fphys.2018.00905
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Dynamics of sub-systems and processes related to respiration.
| Lung Recruitment | 1.8 … 10.7 | 0.09 … 0.60 | Neumann et al., |
| Ca2+ mobilization | 9 … 13 | 0.08 … 0.11 | Wirtz and Dobbs, |
| Lung derecruitment | 20 … 26.5 | 0.04 … 0.05 | Haller et al., |
| Surfactant prod./release | 19.7 … 94.6 | 0.01 … 0.05 | Bates and Irvin, |
| HPV | 120.151 | 0.008 … 0.007 | Sylvester et al., |
HPV, Hypoxic pulmonary vasoconstriction.
Figure 1Graphical illustration of part of the tidal volume (V) series from period pattern P10. Original V values were randomly generated following a Gaussian distribution (white noise), with respective probability density (left). V values were then taken from each of the five probability density regions shown (quintiles of the original random V series) and re-ordered from lowest to highest (+slope) and highest to lowest (−slope) V values, repetitively. V represents V in the second quintile during +slope, while V represents V in the fourth quintile during −slope. V and VTi− represent V in the third quintile during−slope and +slope, respectively, which value is close to the mean of 6 mL/kg. The period pattern P04 was generated similarly, dividing the probability distribution curve into two density regions only.
Figure 2Tracing records of airway flow, volume, and airway pressure (Paw) in one representative animal per group. (A) Conventional volume controlled ventilation (VCV); (B) variable ventilation with Gaussian white noise pattern (WN); (C) variable ventilation with periodicity of 4 cycles (P04) and (D) variable ventilation with periodicity of 10 cycles (P10).
Figure 3Arterial oxygenation (PaO2/FIO2) and arterial carbon-dioxide partial pressure PaCO2 at baseline 1 (BL1), injury and baseline 2 (BL2) and during subsequent therapy. PaO2 was significantly increased only for P10 compared to VCV.
Hemodynamics and oxygen derived parameters.
| VCV | 11.8 ± 5.2 | 58.1 ± 09 | 44 ± 22 | 27.9 ± 15 | 20.1 ± 08 | 18 ± 7.5 | 25 ± 25 | 16 ± 5.7 | 15 ± 5.4 | ||
| WN | 10.8 ± 5.3 | 59.8 ± 16 | 45 ± 16 | 23.5 ± 12 | 24.5 ± 20 | 15 ± 5.7 | 13 ± 4.0 | 12 ± 4.7 | 12 ± 6.1 | ||
| P04 | 11.9 ± 4.6 | 57.7 ± 13 | 44 ± 12 | 19.6 ± 6.2 | 14.5 ± 4.5 | 12 ± 3.5 | 12 ± 5.5 | 12 ± 6.1 | 12 ± 6.3 | ||
| P10 | 13.0 ± 4.4 | 51.8 ± 15 | 37 ± 11 | 16.8 ± 3.6 | 14.0 ± 3.3 | 12 ± 2.7 | 11 ± 3.1 | 10 ± 5.0 | 09 ± 4.4 | ||
| VCV | 4.6 ± 1 | 5.4 ± 2.1 | 4.9 ± 2.1 | 4.2 ± 1.4 | 3.7 ± 0.9 | 3.5 ± 0.7 | 3.6 ± 0.8 | 3.6 ± 0.8 | 3.5 ± 0.8 | ||
| WN | 5.0 ± 1.0 | 6.1 ± 1.6 | 5.1 ± 1.4 | 4.3 ± 0.7 | 3.9 ± 0.6 | 3.8 ± 0.6 | 3.9 ± 0.6 | 3.9 ± 0.5 | 3.9 ± 0.6 | ||
| P04 | 5.3 ± 1.2 | 5.8 ± 1.7 | 5.3 ± 1.1 | 4.1 ± 1.1 | 3.7 ± 0.8 | 3.5 ± 0.6 | 3.5 ± 0.7 | 3.6 ± 0.8 | 3.5 ± 0.8 | ||
| P10 | 4.7 ± 1.1 | 4.6 ± 0.7 | 4.4 ± 0.9 | 3.8 ± 0.8 | 3.6 ± 0.8 | 3.7 ± 0.7 | 3.4 ± 0.8 | 3.4 ± 0.8 | 3.4 ± 0.9 | ||
| VCV | 97.5 ± 14 | 101 ± 14 | 96.0 ± 15 | 88.0 ± 12 | 83.2 ± 9 | 82.4 ± 10 | 79.1 ± 11 | 78.0 ± 10 | 79.5 ± 11.0 | ||
| WN | 94.1 ± 12 | 103 ± 15 | 93.4 ± 12 | 83.2 ± 12 | 82.1 ± 12 | 78.8 ± 10 | 77.0 ± 8 | 76.0 ± 6.6 | 73.2 ± 7.5 | ||
| P04 | 92.8 ± 7.6 | 105 ± 19 | 98.1 ± 9.9 | 83.5 ± 7.8 | 80.7 ± 5.5 | 78.3 ± 3.4 | 75.7 ± 4.8 | 74.5 ± 5.9 | 72.2 ± 6.7 | ||
| P10 | 101 ± 12 | 95.5 ± 15 | 92.0 ± 13 | 85.3 ± 10 | 83.6 ± 13 | 80.6 ± 14 | 77.3 ± 16 | 75.9 ± 16 | 76.8 ± 17 | ||
| VCV | 72 ± 11 | 89 ± 10 | 89 ± 14 | 90 ± 12 | 88 ± 10 | 86 ± 09 | 85 ± 09 | 82 ± 08 | 80 ± 09 | ||
| WN | 76 ± 09 | 89 ± 19 | 88 ± 11 | 87 ± 08 | 93 ± 11 | 87 ± 12 | 85 ± 12 | 81 ± 12 | 79 ± 09 | ||
| P04 | 74 ± 13 | 92 ± 12 | 92 ± 11 | 91 ± 11 | 88 ± 10 | 88 ± 07 | 85 ± 10 | 83 ± 09 | 79 ± 07 | ||
| P10 | 83 ± 13 | 94 ± 13 | 91 ± 13 | 89 ± 11 | 87 ± 09 | 86 ± 09 | 82 ± 10 | 79 ± 09 | 80 ± 13 | ||
| VCV | 16.7 ± 1.6 | 32 ± 4.5.0 | 30.4 ± 3.7 | 29.2 ± 4.5 | 28.9 ± 4.1 | 31.0 ± 5.4 | 27.4 ± 4.3 | 27.0 ± 3.8 | 25.1 ± 4.0 | ||
| WN | 22.0 ± 19.0 | 33.9 ± 5.0 | 30.7 ± 5.5 | 28.3 ± 4.3 | 27.9 ± 3.7 | 28.1 ± 2.9 | 28.1 ± 2.6 | 27.0 ± 2.7 | 26.4 ± 2.7 | ||
| P04 | 17.4 ± 4.6 | 32.2 ± 5.9 | 31.7 ± 4.9 | 26.7 ± 4.0 | 27.2 ± 3.9 | 27.4 ± 4.2 | 27.3 ± 4.6 | 27.2 ± 4.2 | 26.3 ± 3.8 | ||
| P10 | 19.3 ± 3.3 | 33.6 ± 3.5 | 30.3 ± 4.3 | 27.6 ± 4.7 | 27.1 ± 5.2 | 27.0 ± 4.8 | 25.1 ± 4.5 | 24.3 ± 4.8 | 25.0 ± 4.5 | ||
Ratio of partial arterial oxygen pressure to fraction of inspired oxygen (P/F Ratio); intrapulmonary shunt (.
Respiratory variables.
| MV (L·min−1) | VCV | 5.2 ± 0.9 | 5.6 ± 1.0 | 8.2 ± 1.3 | 8.1 ± 1.2 | 8.0 ± 1.1 | 7.6 ± 0.7 | 7.5 ± 0.7 | 7.5 ± 0.7 | 7.5 ± 0.7 | |
| WN | 5.8 ± 0.9 | 6.9 ± 1.5 | 9.1 ± 1.2 | 8.9 ± 1.1 | 8.9 ± 1.2 | 8.7 ± 1.2 | 8.5 ± 1.1 | 8.3 ± 1.1 | 8.2 ± 1.2 | ||
| P04 | 5.8 ± 1.2 | 6.1 ± 1.4 | 9.1 ± 1.3 | 8.9 ± 1.3 | 8.4 ± 1.5 | 8.3 ± 1.4 | 8.1 ± 1.3 | 7.9 ± 1.1 | 7.5 ± 1.0 | ||
| P10 | 5.4 ± 1.0 | 5.9 ± 1.4 | 8.6 ± 1.6 | 8.1 ± 1.2 | 8.1 ± 1.3 | 7.9 ± 1.5 | 7.9 ± 1.5 | 7.5 ± 1.6 | 7.6 ± 1.7 | ||
| VT (mL/kg) | VCV | 9.9 ± 0.2 | 10.8 ± 0.4 | 6.6 ± 0.1 | 6.6 ± 0.1 | 6.6 ± 0.2 | 6.6 ± 0.1 | 6.6 ± 0.1 | 6.6 ± 0.1 | 6.6 ± 0.1 | |
| WN | 9.9 ± 0.7 | 10.3 ± 1.2 | 6.5 ± 0.2 | 6.4 ± 0.2 | 6.4 ± 0.2 | 6.4 ± 0.2 | 6.4 ± 0.2 | 6.4 ± 0.1 | 6.4 ± 0.1 | ||
| P04 | 10.3 ± 0.6 | 10.5 ± 0.7 | 6.6 ± 0.1 | 6.5 ± 0.2 | 6.3 ± 0.4 | 6.4 ± 0.1 | 6.4 ± 0.2 | 6.5 ± 0.1 | 6.4 ± 0.1 | ||
| P10 | 10.0 ± 0.4 | 10.7 ± 0.4 | 6.6 ± 0.2 | 6.3 ± 0.4 | 6.3 ± 0.4 | 6.3 ± 0.4 | 6.4 ± 0.4 | 6.3 ± 0.6 | 6.4 ± 0.4 | ||
| RR (min−1) | VCV | 13.7 ± 2.2 | 13.6 ± 2.2 | 32.3 ± 3.4 | 32.3 ± 2.5 | 31.8 ± 2.8 | 30.5 ± 4.0 | 30.1 ± 3.9 | 30.2 ± 4.3 | 30.2 ± 4.3 | |
| WN | 13.9 ± 1.9 | 16.4 ± 5.9 | 33.1 ± 3.6 | 33.2 ± 3.5 | 33.0 ± 4.2 | 32.1 ± 4.1 | 31.5 ± 3.9 | 30.9 ± 3.7 | 30.4 ± 3.8 | ||
| P04 | 13.4 ± 2.3 | 13.6 ± 2.4 | 32.5 ± 1.9 | 32.5 ± 2.4 | 31.5 ± 3.5 | 30.4 ± 3.6 | 29.9 ± 3.5 | 29.0 ± 3.4 | 27.8 ± 3.8 | ||
| P10 | 14.3 ± 2.8 | 14.6 ± 3.3 | 33.8 ± 1.8 | 33.8 ± 1.7 | 33.5 ± 1.6 | 32.3 ± 2.4 | 32.3 ± 2.4 | 31.2 ± 2.1 | 31.9 ± 3.3 | ||
| Paw, peak (cm H2O) | VCV | 18.2 ± 1.6 | 36.9 ± 4.5 | 32.4 ± 2.3 | 32.0 ± 2.2 | 31.1 ± 2.4 | 30.8 ± 1.9 | 30.5 ± 1.9 | 30.2 ± 1.9 | 29.7 ± 2.0 | |
| WN | 18.5 ± 1.6 | 37.3 ± 4.1 | 34.0 ± 3.3 | 30.2 ± 3.2 | 29.4 ± 3.4 | 29.1 ± 3.4 | 29.1 ± 3.3 | 28.7 ± 3.6 | 28.5 ± 4.0 | ||
| P04 | 19.3 ± 2.7 | 36.4 ± 3.7 | 33.3 ± 2.7 | 29.5 ± 3.4 | 28.9 ± 3.8 | 28.3 ± 3.8 | 28.1 ± 3.9 | 27.9 ± 4.3 | 27.6 ± 4.4 | ||
| P10 | 18.8 ± 1.7 | 37.7 ± 4.6 | 32.2 ± 3.1 | 28.8 ± 3.5 | 28.0 ± 3.4 | 27.3 ± 3.5 | 26.9 ± 3.5 | 26.9 ± 3.4 | 26.0 ± 3.5 | ||
| Paw, plat (cm H2O) | VCV | 14.9 ± 1.2 | 30.5 ± 1.9 | 29.8 ± 2.2 | 29.5 ± 2.0 | 28.8 ± 2.3 | 28.6 ± 1.9 | 28.3 ± 1.9 | 28.1 ± 2.0 | 27.7 ± 2.1 | |
| WN | 15.4 ± 1.2 | 32.5 ± 2.9 | 31.4 ± 3.1 | 27.9 ± 3.3 | 27.3 ± 3.5 | 27.0 ± 3.5 | 27.0 ± 3.5 | 26.6 ± 3.7 | 26.4 ± 4.1 | ||
| P04 | 15.4 ± 3.3 | 30.8 ± 3.2 | 30.9 ± 2.8 | 27.3 ± 3.2 | 26.8 ± 3.6 | 26.1 ± 3.6 | 25.9 ± 3.6 | 25.7 ± 4.1 | 25.4 ± 4.3 | ||
| P10 | 15.1 ± 1.6 | 31.0 ± 3.4 | 29.4 ± 2.4 | 26.5 ± 3.1 | 25.7 ± 3.1 | 25.1 ± 3.1 | 24.7 ± 3.1 | 24.2 ± 3.1 | 23.8 ± 3.2 | ||
| Paw, mean (cm H2O) | VCV | 10.4 ± 0.5 | 17.4 ± 1.2 | 20.0 ± 0.8 | 19.9 ± 0.8 | 19.5 ± 0.9 | 19.5 ± 0.7 | 19.4 ± 0.7 | 19.3 ± 0.7 | 19.2 ± 0.7 | |
| WN | 10.4 ± 0.6 | 18.5 ± 1.8 | 20.6 ± 1.2 | 18.9 ± 1.2 | 18.6 ± 1.3 | 18.5 ± 1.3 | 18.5 ± 1.3 | 18.3 ± 1.4 | 18.4 ± 1.5 | ||
| P04 | 10.5 ± 1.1 | 17.1 ± 1.5 | 20.1 ± 1.0 | 18.5 ± 1.1 | 18.5 ± 1.3 | 18.1 ± 1.2 | 18.1 ± 1.3 | 17.8 ± 1.5 | 17.9 ± 1.5 | ||
| P10 | 10.4 ± 0.8 | 17.1 ± 1.7 | 19.9 ± 1.2 | 18.4 ± 1.3 | 18.1 ± 1.2 | 17.8 ± 1.3 | 17.6 ± 1.3 | 17.8 ± 1.1 | 17.3 ± 1.2 | ||
| R (cm H2O/L/s) | VCV | 6.6 ± 1.0 | 11.5 ± 3.1 | 6.9 ± 1.1 | 6.7 ± 1.0 | 6.3 ± 0.9 | 6.2 ± 0.9 | 6.2 ± 0.9 | 6.1 ± 0.9 | 5.9 ± 0.9 | |
| WN | 6.5 ± 1.7 | 10.8 ± 2.9 | 7.0 ± 1.7 | 6.3 ± 1.1 | 5.8 ± 1.0 | 5.8 ± 1.0 | 5.8 ± 1.0 | 5.6 ± 1.2 | 5.6 ± 1.0 | ||
| P04 | 6.8 ± 1.1 | 10.6 ± 2.2 | 6.7 ± 1.0 | 6.2 ± 1.0 | 5.9 ± 1.2 | 5.9 ± 1.0 | 5.6 ± 1.1 | 5.6 ± 1.1 | 5.5 ± 1.1 | ||
| P10 | 7.4 ± 1.3 | 12.1 ± 2.9 | 7.4 ± 1.4 | 6.6 ± 1.4 | 6.3 ± 1.3 | 6.1 ± 1.2 | 5.9 ± 1.2 | 6.1 ± 0.9 | 5.8 ± 1.2 | ||
| E1 (cm H2O/L) | VCV | 20.5 ± 4.1 | 50.5 ± 21 | 33.0 ± 8.3 | 30.8 ± 8.2 | 28.5 ± 7.0 | 26.2 ± 6.0 | 26.0 ± 6.0 | 25.6 ± 5.5 | 24.7 ± 6.0 | |
| WN | 17.2 ± 3.1 | 45.1 ± 13 | 30.6 ± 6.7 | 30.1 ± 7.1 | 28.5 ± 8.1 | 27.3 ± 9.0 | 28.1 ± 8.7 | 26.0 ± 9.2 | 26.3 ± 8.2 | ||
| P04 | 18.9 ± 3.7 | 44.4 ± 20 | 30.4 ± 9.0 | 29.1 ± 7.8 | 29.0 ± 10.0 | 27.7 ± 9.4 | 26.9 ± 10.0 | 26.1 ± 9.9 | 26.0 ± 11.0 | ||
| P10 | 21.6 ± 5.0 | 51.9 ± 22 | 32.8 ± 8.8 | 31.6 ± 7.6 | 29.2 ± 6.6 | 27.0 ± 6.7 | 25.9 ± 6.1 | 26.7 ± 5.6 | 25.2 ± 6.3 | ||
| E2 (cm H2O/L2) | VCV | 12 ± 6.0 | 39 ± 44 | 156 ± 53 | 162 ± 52 | 160 ± 65 | 166 ± 52 | 162 ± 50 | 159 ± 49 | 154 ± 48 | |
| WN | 11 ± 1.9 | 44 ± 31 | 141 ± 40 | 95 ± 27 | 93 ± 31 | 90 ± 27 | 87 ± 25 | 90 ± 28 | 85 ± 33 | ||
| P04 | 10 ± 12 | 24 ± 33 | 139 ± 50 | 93 ± 39 | 87 ± 43 | 82 ± 46 | 85 ± 49 | 84 ± 53 | 83 ± 54 | ||
| P10 | 13 ± 8.4 | 39 ± 69 | 152 ± 67 | 108 ± 31 | 97 ± 31 | 93 ± 29 | 89 ± 28 | 86 ± 27 | 77 ± 28 |
Baseline 1 (BL1), Injury (IN), Baseline 2 (BL2). Minute ventilation (MV); respiratory rate (RR); mean VT per kg (VT); peak airway pressures (Paw, peak); plateau airway pressures (Paw, plat); mean airway pressure (Paw, mean); resistance of the respiratory system (R); elastance of the respiratory system (E); volume-independent elastance (E1); volume dependent elastance (E2); volume-dependence index of respiratory system elastance (%E2); conventional volume controlled ventilation (VCV); variable volume controlled ventilation with Gaussian white noise pattern in tidal volume (WN); variable volume controlled ventilation with periodicity of 4 cycles (P04) and variable volume controlled ventilation with periodicity of 10 cycles (P10). Values are shown as mean and standard deviation, and were obtained from 40 animals in total (n = 10/group). There were no missing values. Statistical significance was accepted at p < 0.05. Comparability of groups at Injury and BL2 was tested using one-way ANOVA followed by Bonferroni post-hoc tests. Differences among groups (group main effect) were tested with general linear model statistics using values at BL2 as covariate and adjusted for repeated measurements according to the Sidak procedure
p < 0.01,
p < 0.001).
Figure 4Dynamic respiratory system elastance (E) and relative volume dependence of E (%E2) at baseline 1 (BL1), injury and baseline 2 and during subsequent therapy period. In all patterns of variable ventilation E and %E2 were significantly reduced compared to VCV.
Figure 5Correlation between arterial partial oxygen pressure to inspiratory oxygen fraction ratio (PaO2/FiO2) and dynamic respiratory system elastance (E) at end of the therapy period. Straight continuous and dashed lines represent linear regression lines without and with outliers, respectively; the coefficients of determination (R2) were calculated excluding outliers.
Figure 6Left: difference between tidal volume (V) in the descending limb of a given cycle and in the ascending limb of the preceding cycle (ΔV) (see also text and Figure 1); Right: difference of dynamic respiratory system elastance (ΔE) calculated for cycles with VT value close to the mean (6 mL/kg) in the descending and in the ascending slopes (V- and V+, respectively) of the respective pattern.
Diffuse alveolar damage.
| Alveolar edema | VCV | 2[0–4] | n.s. | 1[0–2] | n.s. |
| WN | 4[1–6] | 1[0–4] | |||
| P04 | 1[0–8] | 2[0–4] | |||
| P10 | 2[0–6] | 1[1–3] | |||
| Intersitial edema | VCV | 1[1–4] | n.s. | 1[0–4] | n.s. |
| WN | 2[1–4] | 1[1–3] | |||
| P04 | 1[1–4] | 1[1–2] | |||
| P10 | 2[1–4] | 1[1–4] | |||
| Hemorrhage | VCV | 1[0–3] | n.s. | 1[0–1] | n.s. |
| WN | 2[1–4] | 1[0–2] | |||
| P04 | 1[0–4] | 2[0–3] | |||
| P10 | 2[0–6] | 1[0–3] | |||
| Inflammatory infiltration | VCV | 8[3–12] | n.s. | 3[1–6] | n.s. |
| WN | 12[5–15] | 3[2–6] | |||
| P04 | 6[2–12] | 5[2–8] | |||
| P10 | 8[1–12] | 3[1–8] | |||
| Epithelial destruction | VCV | 4[1–4] | n.s. | 1[0–4] | n.s. |
| WN | 3[1–6] | 1[1–6] | |||
| P04 | 1[0–6] | 2[1–9] | |||
| P10 | 1[1–8] | 4[1–9] | |||
| Microatelectasis | VCV | 4[1–4] | n.s. | 1[1–4] | n.s. |
| WN | 2[1–4] | 1[1–2] | |||
| P04 | 2[1–4] | 2[1–4] | |||
| P10 | 2[1–4} | 1[1–2] | |||
| Overdistension | VCV | 3[1–6] | n.s. | 1[0–3] | n.s. |
| WN | 4[1–8] | 1[0–2] | |||
| P04 | 5[0–8] | 2[0–3] | |||
| P10 | 6[4–7] | 1[0–3] | |||
| Cumulative score | VCV | 26[13–33] | n.s. | 12[3–20] | n.s. |
| WN | 33[18–43] | 13[7–17] | |||
| P04 | 21[5–48] | 18[8–27] | |||
| P10 | 26[9–45] | 14[6–25] |
Diffuse alveolar damage in ventral and dorsal lung regions. Conventional volume controlled ventilation (VCV); variable volume controlled ventilation with Gaussian white noise pattern (WN); variable volume controlled ventilation with periodicity of 4 cycles (P.
Figure 7Histological slides with HE-staining at 100-fold magnification of representative animals.
Gene expression of markers of inflammation and cell stress.
| TNF-α | VCV | 1.0 | n.s. | 1.0 | n.s. |
| WN | 1.0 [0.6–1.9] | 0.7 [0.3–1.0] | |||
| P04 | 1.0 [0.7–1.7] | 0.6 [0.5–1.5] | |||
| P10 | 1.4 [0.7–2.3] | 0.7 [0.5–1.3] | |||
| IL-6 | VCV | 1.0 | n.s. | 1.0 | n.s. |
| WN | 0.9 [0.6–1.2] | 0.9 [0.5–1.5] | |||
| P04 | 0.9 [0.2–1.3] | 0.7 [0.4–1.3] | |||
| P10 | 0.8 [0.3–1.4] | 0.8 [0.4–1.4] | |||
| IL-8 | VCV | 1.0 | n.s. | 1.0 | n.s. |
| WN | 1.5 [0.8–2.1] | 1.2 [0.5–2.1] | |||
| P04 | 1.4 [0.2–3.6] | 0.3 [0.2–2.5] | |||
| P10 | 1.5 [0.4–2.7] | 0.9 [0.6–1.3] | |||
| Amphiregulin | VCV | 1.0 | n.s. | 1.0 | n.s. |
| WN | 0.9[0.5–1.6] | 1.2 [0.5–2.2] | |||
| P04 | 1.2 [0.5–2.0] | 0.5 [0.3–1.4] | |||
| P10 | 1.6 [0.6–3.5] | 1.0 [0.7–1.5] | |||
| Tenascin-c | VCV | 1.0 | n.s. | 1.0 | n.s. |
| WN | 1.3 [0.6–2.2] | 1.0 [0.5–2.2] | |||
| P04 | 1.2 [0.8–2.1] | 1.2 [0.8–1.8] | |||
| P10 | 1.0 [0.6–5.6] | 1.6 [0.5–2.2] |
Gene expression of Tumor necrosis factor (TNF)-α, Interleukin (IL)-6, Interleukin (IL)-8, Amphiregulin and Tenascin-c in ventral lung regions (ventral) and dorsal lung regions (dorsal), conventional volume controlled ventilation (VCV); variable volume controlled ventilation with Gaussian white noise pattern in tidal volume (WN); variable volume controlled ventilation with periodicity of 4 cycles (P.
Levels of inflammation markers in lung tissue.
| TNF-α (pg/mg) | VCV | 2.8 [1.9–7.5] | n.s. | 3.0 [2.4–5.8] | n.s. |
| WN | 2.4 [0.4–4.7] | 4.3 [1.4–10.7] | |||
| P04 | 3.2 [1.1–4.8] | 3.8 [1.0–5.6] | |||
| P10 | 1.1 [0.6–4.8] | 2.9 [1.1–7.4] | |||
| IL-6 (pg/mg) | VCV | 39.5 [18.9–102.8] | n.s. | 28.2 [8.6–50.1] | n.s. |
| WN | 31.8 [18.7–50.0] | 34.9 [13.7–106.3] | |||
| P04 | 26.0 [14.4–59.2] | 14.4 [7.0–44.8] | |||
| P10 | 39.1 [23.4–60.5] | 20.4 [8.4–34.9] | |||
| IL-8 (pg/mg) | VCV | 133.7 [63.1–327.5] | n.s. | 106.1 [62.5–286.2] | n.s. |
| WN | 118.0 [48.1–226.0] | 125.0 [68.8–216.4] | |||
| P04 | 120.3 [37.5–474.1] | 88.75 [48.5–208.0] | |||
| P10 | 90.6 [70.5–118.0] | 101.9 [72.5–130.9] |
Gene expression of Tumor necrosis factor (TNF)-α, Interleukin (IL)-6, Interleukin (IL)-8, in ventral lung regions (ventral) and dorsal lung regions (dorsal), conventional volume controlled ventilation (VCV); variable volume controlled ventilation with Gaussian white noise pattern in tidal volume (WN); variable volume controlled ventilation with periodicity of 4 cycles (P.